In this issue:
Predictive value of symptoms, signs and biomarkers on CTPA
High CTPA use affects PE diagnostic yield
Low-dose perfusion scans for detecting PE during pregnancy
Recurrent VTE risk factors following unprovoked PE
Pharmacomechanical catheterdirected thrombolysis for DVT
Age should not preclude pulmonary endarterectomy in selected patients
Macitentan for inoperable CTEPH
Switching to riociguat in PAH after inadequate PDE-5 inhibitor response
Management and long-term outcomes of sarcoidosis-associated PH
Idiopathic PAH survival in the modern era in Australia/NZ
Please login below to download this issue (PDF)